BridgeMD
New treatment option for Surgery
Official title Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery
ClinicalTrials.gov ID: NCT05197972
What this study is testing
- What it's testing
- The investigator proposes to use the cardiac coherence technique (Cardiac Coherence) coupled with a hypnosis session to reduce pre-operative anxiety.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years old
- Patient with a scheduled surgery for a cancer (suspected or declared) with a classic or ambulatory hospitalization
- Patients requiring general anesthesia with or without associated loco-regional anesthesia or loco-regional anesthesia alone
- Patient with a smartphone or a tablet or a computer and able to install the application
- Inclusion of the patient minimum 7 days before the date of the surgery
You likely can't join if
- Emergency surgery
- Plastic surgery for reconstruction: lipomodelling
- Prophylactic surgery: no suspected or existing cancer
- Bradycardia (\< 50 beats/minute) with β-blockers
- Severe heart failure with ventricular ejection fraction \< 40%
- Uncontrolled chronic pain for more than three months on morphine
See the full eligibility criteria
- Age ≥ 18 years old
- Patient with a scheduled surgery for a cancer (suspected or declared) with a classic or ambulatory hospitalization
- Patients requiring general anesthesia with or without associated loco-regional anesthesia or loco-regional anesthesia alone
- Patient with a smartphone or a tablet or a computer and able to install the application
- Inclusion of the patient minimum 7 days before the date of the surgery
- Patient who signed the informed consent
- Patient affiliated to a French social security system
- Emergency surgery
- Plastic surgery for reconstruction: lipomodelling
- Prophylactic surgery: no suspected or existing cancer
- Bradycardia (\< 50 beats/minute) with β-blockers
- Severe heart failure with ventricular ejection fraction \< 40%
- Uncontrolled chronic pain for more than three months on morphine
- Patient with unstable epilepsy or respiratory pathology with rest dyspnea
- Patient used to and having a regular and habitual practice of relaxation techniques such as yoga, hypnosis, sophrology, meditation, music therapy, virtual reality, ...
- Medical (neurological, psychiatric, etc.) or psychological conditions not allow for participation in the protocol (completion of questionnaires and booklet, compliance with the cardiac coherence program coupled with...
- Deaf patient without hearing aids
- Patient under guardianship or curatorship
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, Hérault, France
- Lyon, France
- Toulouse, France
- Villejuif, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, Hérault, France; Lyon, France; Toulouse, France; Villejuif, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.